Gabapentin
Aliases: Gralise, Gabbies, Gabarone, Neurontin
Summary
Gabapentin (also known as Neurontin) is a depressant substance of the gabapentinoid class. It is a structural analog of the neurotransmitter GABA and acts by inhibiting certain calcium channels in the brain, namely α2δ subunit-containing voltage-dependent calcium channels (VGCCs). Gabapentin was originally developed to treat epilepsy and is currently FDA approved to treat postherpetic neuralgia in adults and as an adjunctive therapy in the treatment of partial onset seizures.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral BA 27%-60% | 200-900mg | 900-1500mg | 1500-2400mg | 2400mg+ |
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | Total |
|---|---|---|---|---|
| Oral | 0.5-2 hrs | 2-3 hrs | 2-4 hrs | 4.5-9 hrs |
Tolerance
Tolerance Decay
Tolerance to the desirable sedative/euphoric effects can appear within days to weeks of daily or near‑daily use; anecdotal reports suggest partial reversal after 3–7 days off and near‑baseline within ~2 weeks. Cross‑tolerance with pregabalin is expected due to shared α2δ subunit mechanism; exact magnitude is uncertain (estimate shown is heuristic). Data quality is limited and based largely on clinical observation plus community reports; taper if using regularly to avoid withdrawal symptoms.
Cross-Tolerances
Effects
Aggregated from 178 Erowid and 31 Bluelight experience reports